RYAN ARTHUR F

USNatural personDirector

FrançaisSign in Try free 14d

Insider

RYAN ARTHUR F

USNatural personDirector

Transactions

848

Issuers

Buys / Sells

4/702

Last tx

01 May 2026

Behaviour

3 purchases reported after at least 12 months of silence — most recent on 29 Sept 2014.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
PRUDENTIAL FINANCIAL INC	308,587	reported	12 Feb 2008	tx 18+1,460,816−135,462
CITIZENS FINANCIAL GROUP INC/RI	60,993.6	reported	14 Feb 2019	tx 15+60,993.61
REGENERON PHARMACEUTICALS, INC.	17,559	reported	01 May 2026	tx 811+451,520−463,754
Universal Business Payment Solutions Acquisition Corp	2	reported	28 Dec 2012	tx 4+17,266−20,955

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	1	712.09 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	5	701.76 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	15	702.46 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	24	703.46 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	15	704.28 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	14	705.56 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	7	706.74 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	4	707.40 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	6	709.45 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	710.87 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	5	711.49 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	714.13 USD	10b5-1
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	20	788.96 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	787.34 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	7	786.61 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	11	785.48 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	781.21 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	10	783.62 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	782.62 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	7	777.46 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	778.30 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	5	779.69 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	3	780.69 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	20	789.28 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	9	784.48 USD

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
PRUDENTIAL FINANCIAL INC	308,587	reported	12 Feb 2008	tx 18+1,460,816−135,462
CITIZENS FINANCIAL GROUP INC/RI	60,993.6	reported	14 Feb 2019	tx 15+60,993.61
REGENERON PHARMACEUTICALS, INC.	17,559	reported	01 May 2026	tx 811+451,520−463,754
Universal Business Payment Solutions Acquisition Corp	2	reported	28 Dec 2012	tx 4+17,266−20,955

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	1	712.09 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	5	701.76 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	15	702.46 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	24	703.46 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	15	704.28 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	14	705.56 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	7	706.74 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	4	707.40 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	6	709.45 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	710.87 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	5	711.49 USD	10b5-1
01 May 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	714.13 USD	10b5-1
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	20	788.96 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	787.34 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	7	786.61 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	11	785.48 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	781.21 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	10	783.62 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	782.62 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	7	777.46 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	2	778.30 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	5	779.69 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	3	780.69 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	20	789.28 USD
02 Mar 2026	SALE	REGENERON PHARMACEUTICALS, INC.	9	784.48 USD